Home » Stocks » Novan

Novan, Inc. (NOVN)

Stock Price: $0.501 USD -0.010 (-1.86%)
Updated Oct 27, 2020 4:00 PM EDT - Market closed
After-hours: $0.500 -0.001 (-0.10%) Oct 27, 7:58 PM

Stock Price Chart

Key Info

Market Cap 68.80M
Revenue (ttm) 5.23M
Net Income (ttm) -19.51M
Shares Out 137.47M
EPS (ttm) -0.70
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $0.501
Previous Close $0.510
Change ($) -0.010
Change (%) -1.86%
Day's Open 0.519
Day's Range 0.490 - 0.520
Day's Volume 2,610,812
52-Week Range 0.215 - 3.720

More Stats

Market Cap 68.80M
Enterprise Value 39.72M
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 137.47M
Float 127.40M
EPS (basic) -0.47
EPS (diluted) -0.70
FCF / Share -0.42
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 5.56M
Short Ratio 0.54
Short % of Float 4.36%
Beta -0.29
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 13.16
PB Ratio n/a
Revenue 5.23M
Operating Income -29.87M
Net Income -19.51M
Free Cash Flow -33.47M
Net Cash 29.09M
Net Cash / Share 0.21
Gross Margin -96.00%
Operating Margin -571.26%
Profit Margin -373.10%
FCF Margin -640.10%
ROA -36.36%
ROE n/a
ROIC -282.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$3.00*
(499.40% upside)
Low
1.50
Current: $0.501
High
4.50
Target: 3.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014
Revenue4.905.992.65--0.11
Revenue Growth-18.28%126.42%----
Gross Profit4.905.992.65--0.11
Operating Income-30.69-28.56-35.68-59.83-25.83-11.83
Net Income-30.38-29.24-36.62-59.70-28.06-11.39
Shares Outstanding26.2525.8015.985.992.272.20
Earnings Per Share-1.16-1.13-2.29-9.97-12.37-5.17
Operating Cash Flow-19.88-28.63-29.86-49.17-22.19-8.60
Capital Expenditures-0.42-1.06-2.14-6.22-1.21-0.77
Free Cash Flow-20.30-29.68-32.00-55.39-23.40-9.38
Cash & Equivalents14.258.733.0635.1546.237.42
Total Debt6.268.028.038.040.010.02
Net Cash / Debt7.990.71-4.9727.1146.227.40
Assets29.1026.3621.1352.4749.829.93
Liabilities51.3819.9222.8521.415.101.78
Book Value-22.286.44-1.7231.07-60.08-29.55
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Novan, Inc.
Country United States
Employees 25
CEO Paula Brown Stafford

Stock Information

Ticker Symbol NOVN
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: NOVN
IPO Date September 21, 2016

Description

Novan, Inc., a clinical development-stage biotechnology company, focuses on the development and commercialization of nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology product candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, a topical anti-viral product candidate. Novan, Inc. has a license agreement with Sato Pharmaceutical Company; and a strategic alliance with Orion Corporation. The company was founded in 2006 and is headquartered in Morrisville, North Carolina.